Home|DSIJArticleDetail

Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?
Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?

Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?

Expansion plan will help the hospital company to increase market share and cater to the increasing demand for quality healthcare service

Aniket Gogate Article rating: 4.3

Apollo Hospitals Enterprise Ltd, one of India's leading healthcare providers, is gearing up for a massive expansion drive with a capex plan of Rs 3,435 crore to add 2,285 beds over the next 3-4 years. This ambitious move is a bullish bet on the future of Indian healthcare, which is poised to grow rapidly in the coming years.

Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!
Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!

Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!

The stock has a PE multiple of 8.98, while the sectoral PE multiple is 32.8, the ROE is 44.60 per cent and the ROCE is 45.74 per cent.

Kiran Shroff Article rating: 4.0

The stock has a PE multiple of 8.98, while the sectoral PE multiple is 32.8, the ROE is 44.60 per cent and the ROCE is 45.74 per cent.

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!
Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

Kiran Shroff Article rating: 4.3

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

 

DSIJ MINDSHARE

Mkt Commentary3-May, 2024

Penny Stocks3-May, 2024

Multibaggers3-May, 2024

Mindshare3-May, 2024

Penny Stocks3-May, 2024

Knowledge

MF2-May, 2024

General2-May, 2024

Technical1-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList